180 Life Sciences Corp.
ATNF
$1.80
-$0.0099-0.55%
Headlines
9/13/2024
-
Invezz News
9/12/2024
-
SeekingAlpha.com: All News
9/12/2024
-
TipRanks Financial Blog
9/12/2024
-
The Fly
9/12/2024
-
Globe Newswire
8/30/2024
-
Ticker Report
8/13/2024
-
Zolmax
8/13/2024
-
InvestorPlace
7/30/2024
-
The Fly
7/30/2024
-
Globe Newswire
7/23/2024
-
The Fly
7/23/2024
-
Globe Newswire
7/19/2024
-
SeekingAlpha.com: All News
7/19/2024
-
The Fly
7/15/2024
-
Zolmax
7/15/2024
-
Ticker Report
7/11/2024
-
TipRanks Financial Blog
7/2/2024
-
The Fly
7/2/2024
-
Globe Newswire
7/2/2024
-
Zolmax
7/2/2024
-
Ticker Report
6/14/2024
-
Zolmax
6/13/2024
-
Ticker Report
Filings
Monday, August 12, 2024
Sunday, June 30, 2024
Week of Nov 4 and 8 (est)
Price History
Corporate Info
650 507 0669
Building 4
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
--
Business Description
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory...
more